🇺🇸 Insulin Asparte in United States
10 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 23 April 2025 – 23 April 2026
- Total reports: 10
Most-reported reactions
- Abnormal Behaviour — 1 report (10%)
- Accidental Exposure To Product — 1 report (10%)
- Acute Kidney Injury — 1 report (10%)
- Aggression — 1 report (10%)
- Amnesia — 1 report (10%)
- Anal Atresia — 1 report (10%)
- Atrial Septal Defect — 1 report (10%)
- Bladder Agenesis — 1 report (10%)
- Blood Glucose Decreased — 1 report (10%)
- Blood Glucose Fluctuation — 1 report (10%)
Other Diabetes approved in United States
Frequently asked questions
Is Insulin Asparte approved in United States?
Insulin Asparte does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for Insulin Asparte in United States?
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) is the originator. The local marketing authorisation holder may differ — check the official source linked above.